These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 5076528

  • 1. Clinical study of verospirone and spironolactone.
    Gãbor G, Bekes M, Polãk G, Rausch J, Gulyãs A.
    Ther Hung; 1972; 20(1):36-45. PubMed ID: 5076528
    [No Abstract] [Full Text] [Related]

  • 2. [Diuresis therapy in hyperaldosteronism].
    Wallnöfer H, Hanusch M.
    Wien Med Wochenschr; 1966 Dec 24; 116(52):1159-64. PubMed ID: 5996768
    [No Abstract] [Full Text] [Related]

  • 3. Secondary aldosteronism in refractory edema.
    Seller RH, Ramirez O, Brest AN.
    GP; 1967 Apr 24; 35(4):104-11. PubMed ID: 6022062
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
    Gorbach HC, Bräuninger HJ.
    MMW Munch Med Wochenschr; 1975 Sep 24; 117(37):1483-6. PubMed ID: 810673
    [Abstract] [Full Text] [Related]

  • 5. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
    Fraisse H, Perret M, Etaix JP.
    J Med Lyon; 1967 Feb 05; 48(114):173-83. PubMed ID: 5600100
    [No Abstract] [Full Text] [Related]

  • 6. Clinico-pharmacological investigation with verospirone.
    Szám I, Vass A, Hegedüs-Wein I.
    Ther Hung; 1973 Feb 05; 21(2):56-60. PubMed ID: 4792877
    [No Abstract] [Full Text] [Related]

  • 7. [Use of a normal sodium diet in the diuretic treatment of refractory cardiac insufficiency].
    Sánchez Torres G, Posadas C, Tena I, Boyer JL, Enríquez C.
    Arch Inst Cardiol Mex; 1982 Feb 05; 52(6):507-15. PubMed ID: 7159133
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone.
    Radó JP, Molnár Z, Hartai A, Gercsák G.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov 05; 20(11):532-7. PubMed ID: 7174156
    [Abstract] [Full Text] [Related]

  • 9. [New aspects of the use of spironolactone and its association with thiabutazide (per os and in injections) in the treatment of grave cardiac insufficiency].
    Căruntu M, Mihail A.
    Med Interna (Bucur); 1974 Feb 05; 26(2):177-88. PubMed ID: 4828933
    [No Abstract] [Full Text] [Related]

  • 10. What's old is new again. Spironolactone and heart failure.
    Lock M, Chun R.
    Can Fam Physician; 1999 Nov 05; 45():2621-2. PubMed ID: 10587769
    [No Abstract] [Full Text] [Related]

  • 11. [Prolonged treatment of ascitic cirrhosis by the combination of a saldiuretic and a spironolactone].
    Tolot F, Dechavannes M, Fiere D.
    Lyon Med; 1966 Jan 02; 215(1):29-35. PubMed ID: 5904663
    [No Abstract] [Full Text] [Related]

  • 12. [The behavior of uricemia during treatment with spironolactone and with other diuretics].
    Bufalari A, Meloni G.
    Minerva Med; 1967 Nov 07; 58(89):3815-22. PubMed ID: 6074933
    [No Abstract] [Full Text] [Related]

  • 13. [Secondary hyperaldosteronism as a secondary disease in intractable cardiac decompensation].
    Antalóczy Z, Ludvigh G.
    Z Arztl Fortbild (Jena); 1965 Jul 15; 59(14):757-61. PubMed ID: 5887150
    [No Abstract] [Full Text] [Related]

  • 14. [Study of the clinical and metabolic effects of an inhibitor of kaliuresis, amipromyzide (MK 870)].
    Guedon M, Cote M, Gay M.
    J Urol Nephrol (Paris); 1968 Jul 15; 74(4):363-9. PubMed ID: 5675118
    [No Abstract] [Full Text] [Related]

  • 15. [Influence of diuretics on the survival of 180 patients with cirrhosis of the liver and ascites].
    Robert M, Portmann B.
    Schweiz Med Wochenschr; 1969 Feb 08; 99(6):178-82. PubMed ID: 5781367
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of spironolactone therapy in patients with heart failure with normal ejection fraction.
    Ozhan H, Balaban Y.
    Heart; 2010 May 08; 96(10):791; author reply 791. PubMed ID: 20448132
    [No Abstract] [Full Text] [Related]

  • 17. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP, Aaronson KD, Koelling TM.
    Am Heart J; 2004 Dec 08; 148(6):971-8. PubMed ID: 15632880
    [Abstract] [Full Text] [Related]

  • 18. [Intolerance to spironolactone in refractory cardiac insufficiency. Probable changes in the aldosterone receptors. Study of 11 cases].
    Sänchez Torres G, Posadas C, Boyer JL, Guzmán Lara J, Serrano P.
    Arch Inst Cardiol Mex; 1981 Dec 08; 51(3):233-40. PubMed ID: 6456707
    [No Abstract] [Full Text] [Related]

  • 19. [Rational use of diuretics in hepatic cirrhosis].
    Vagge R, Cavatorta F, Queirolo C.
    G Clin Med; 1983 Dec 08; 64(3-4):116-23. PubMed ID: 6884638
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical test of a diuretic preparation combining a spironoloctone and a sulfonamide derivative].
    Casanova P, Delboy C.
    Mars Med; 1965 Dec 08; 102(6):551-8. PubMed ID: 5320169
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.